HPQ
37
2
PHM
55
-3
DGX
36
-4
VLO
48
-2
BLK
57
-3
CA
27
9
GPC
57
-4
LEG
58
-4
AMP
67
-5
TMO
50
-4
XOM
40
-8
VRSK
25
-3
MMM
54
-3
D
43
-2
BIIB
46
-3
ITW
37
-6
O
35
-7
XRAY
28
-3
PFE
34
-7
DLTR
64
-2
HPQ
37
2
PHM
55
-3
DGX
36
-4
VLO
48
-2
BLK
57
-3
CA
27
9
GPC
57
-4
LEG
58
-4
AMP
67
-5
TMO
50
-4
XOM
40
-8
VRSK
25
-3
MMM
54
-3
D
43
-2
BIIB
46
-3
ITW
37
-6
O
35
-7
XRAY
28
-3
PFE
34
-7
DLTR
64
-2
Financhill
Back

Allied Properties Real Estate Investment Trust Vs. Nektar Therapeutics Industry Stock Comparison

Sell
25

APYRF
Allied Properties Real Estate Investment Trust

Last Price:
$9.42
Seasonality Move:
1.27%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Sell
25
Allied Properties Real Estate Investment Trust (APYRF) is a Sell

Is Allied Properties Real Estate Investment Trust a Buy, Sell or Hold?

  • The current Allied Properties Real Estate Investment Trust [APYRF] share price is $9.56. The Score for APYRF is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • APYRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APYRF Stock Price Chart

What is Allied Properties Real Estate Investment Trust's stock price today?

  • The Allied Properties Real Estate Investment Trust share price today is $9.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APYRF is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

APYRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 41.05 Sell
Chaikin Money Flow: -19615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.23 - 9.69) Buy
Bollinger Bands (100): (10.31 - 14.51) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.73 - 61.13) Sell
Bollinger Bands (100): (33.63 - 62.73) Buy

APYRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.44 Buy
20-day SMA: 9.38 Buy
50-day SMA: 10.96 Sell
200-day SMA: 12.07 Sell
8-day EMA: 9.49 Buy
20-day EMA: 9.64 Sell
50-day EMA: 10.69 Sell
200-day EMA: 12.06 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Allied Properties Real Estate Investment Trust Earnings Growth & APYRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Allied Properties Real Estate Investment Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):